The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...
A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...
The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung ...
the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...
GlobalData on MSN5d
FDA approves early feasibility study of Valcare’s transcatheter deviceThe US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...
Bengaluru: Health and family welfare minister Dinesh Gundu Rao admitted in the legislative assembly that govt-run healthcare ...
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed for now on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback